4//SEC Filing
BEN-MAIMON CAROLE 4
Accession 0001062993-22-001319
CIK 0001374690other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:16 PM ET
Size
5.5 KB
Accession
0001062993-22-001319
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+182,000→ 182,000 totalExercise: $8.75Exp: 2032-01-18→ Common Stock (182,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on January 18, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Issuer
Larimar Therapeutics, Inc.
CIK 0001374690
Entity typeother
Related Parties
1- filerCIK 0001529611
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 7:16 PM ET
- Size
- 5.5 KB